Cytochrome P450 2C19 (CYP2C19) genotype appears to affect the efficacy of omeprazole

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1221, 2000-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Aging on the Relationship between the Cytochrome P450 2C19 Genotype and Omeprazole Pharmacokinetics

By Ishizawa Yukio   Yasui-Furukori Norio  

Clinical Pharmacokinetics, Vol. 44, Iss. 11, 2005-01 ,pp. : 1179-1189

Adis International

Access to resources Recommend Favorite

Fatal intoxication cases: cytochrome P 450 2D6 and 2C19 genotype distributions

By Zackrisson A.   Holmgren P.   Gladh A.   Ahlner J.   Lindblom B.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 547-552

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs

By Sugimoto Katsuyoshi  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 583-587

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

By Desta Z.   Zhao X.   Shin J-G.   Flockhart D.A.  

Clinical Pharmacokinetics, Vol. 41, Iss. 12, 2002-01 ,pp. : 913-958

Adis International

Access to resources Recommend Favorite

Influence of Cytochrome P450 (CYP) 3A5 Polymorphisms on the Pharmacokinetics of Lansoprazole Enantiomers in CYP2C19 Extensive Metaboliser Renal Transplant Recipients

By Miura Masatomo  

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite